Guide decisions through drug development: Localize critical PTMs at the sub-unit level

Event Overview:

With increasing complexity of novel biopharmaceuticals comes new challenges in developing stable cell lines to produce these treatements. Strategies to gain more information on critical post translational modifications in early development can significantly accelerate drug development timelines. Critical information on drug molecules at the intact level can reduce risk and streamline both downstream and upstream processes. This can be achieved by reducing the time required to gain this information and enabling the use of mass spectrometry assays at critical stages in early development.

This webinar will cover the use of an integrated icIEF-UV/MS workflow on the Intabio ZT system to identify multiple critical post translational modifications (PTMs) at the subunit level. Information gained from this 2-dimensional analysis provides glycan localization, deamidation, C terminal processing, N terminal cyclization, N linked glycosylation with terminal alpha Galactose and neuraminic acid, expanding on the core charge variant characterization applications of the Intabio ZT system.

Key Learning Objectives:

Explore the benefits of gaining PTM information at the subunit level for recombinant proteins
Discover a novel strategy for subunit analysis throughout development
Localize critical PTMs at the sub-unit level to assess potential impact on drug efficacy

Who Should Attend:

Drug development scientists
Lab directors
CDMO, CMO, CRO scientists
Senior scientists

Featured Speakers:

Scott Mack

Principal Scientist

SCIEX

Scott Mack is a Principal Scientist and co-inventor of the Microchip Electrophoresis technology employed in the Intabio ZT system from SCIEX. Prior to joining SCIEX, Scott led icIEF assay development and system integration efforts on the Maurice System. In addition, he developed the advanced cIEF methodology for the PA 800 Plus system and pioneered enhanced cIEF-MS analysis with David Chen’s Lab at the University of British Columbia

Speaker's Email: scott.mack@sciex.com
Speaker's LinkedIn: https://www.linkedin.com/in/scott-mack-71953315/

For any technical questions please contact David Ambrose: dambrose@mjhlifesciences.com

Complete this form to enter the webcast. (* indicates required field)

Guide decisions through drug development: Localize critical PTMs at the sub-unit level

This event is now available on demand.

Complete this form to enter the webcast.
(* indicates required field)